Ana Esparcia1, Arturo Artero2, José M Eiros3, Marta Balaguer1, Manuel Madrazo1, Juan Alberola4, José M Nogueira4. 1. Department of Internal Medicine, Hospital Universitario Dr. Peset, Spain. 2. Department of Internal Medicine, Hospital Universitario Dr. Peset, Universitat de València, Spain. Electronic address: arturo.artero@uv.es. 3. School of Medicine, Universidad de Valladolid, Spain. 4. Department of Microbiology, Hospital Universitario Dr. Peset, Universitat de València, Spain.
Abstract
BACKGROUND: Inadequate empirical antimicrobial therapy (IEAT) in intensive care unit (ICU) is associated with adverse outcomes. However, the influence of IEAT on prognosis for elderly patients with urinary tract infection (UTI) in non-ICU settings is unknown. METHODS: A retrospective cross-sectional study of elderly patients admitted to a non-ICU ward in a university hospital with a primary diagnosis of UTI over a 3-year period was done. Data relating to age, sex, background comorbidities, severity of infection, bacteremia, microorganisms isolated in urine, treatment given, length of stay and prognosis were obtained using chart review. Cases were segregated according to the adequacy of empirical antimicrobial therapy. In-hospital mortality rate was the main outcome variable evaluated. RESULTS: A total of 270 patients with a mean age of 83.7years were studied. Sixty-eight percent were health-care associated infections. Seventy-nine (29.3%) cases received IEAT. IEAT was associated with previous hospitalization, urinary catheter and previous antibiotic. A Gram stain of urine with a gram-positive cocci was predictive of IEAT by multivariate analysis (OR, 6.29; 95% CI, 1.05-37.49). In-hospital mortality rate was 8.9%. IEAT (OR, 3.47; 95% CI, 1.42-8.48) was an independent risk factor for mortality along with APACHE II ≥15 (OR, 3.14; 95% CI, 1.24-7.90), dementia (OR, 3.10; 95% CI, 1.19-8.07) and neoplasia (OR, 3.49; 95% CI, 1.13-10.77). IEAT was not associated with length of stay in hospital. CONCLUSION: IEAT is associated with mortality in elderly patients with UTI admitted to a non-ICU ward, suggesting that improving empirical antimicrobial therapy could have a favorable impact on prognosis. Published by Elsevier B.V.
BACKGROUND: Inadequate empirical antimicrobial therapy (IEAT) in intensive care unit (ICU) is associated with adverse outcomes. However, the influence of IEAT on prognosis for elderly patients with urinary tract infection (UTI) in non-ICU settings is unknown. METHODS: A retrospective cross-sectional study of elderly patients admitted to a non-ICU ward in a university hospital with a primary diagnosis of UTI over a 3-year period was done. Data relating to age, sex, background comorbidities, severity of infection, bacteremia, microorganisms isolated in urine, treatment given, length of stay and prognosis were obtained using chart review. Cases were segregated according to the adequacy of empirical antimicrobial therapy. In-hospital mortality rate was the main outcome variable evaluated. RESULTS: A total of 270 patients with a mean age of 83.7years were studied. Sixty-eight percent were health-care associated infections. Seventy-nine (29.3%) cases received IEAT. IEAT was associated with previous hospitalization, urinary catheter and previous antibiotic. A Gram stain of urine with a gram-positive cocci was predictive of IEAT by multivariate analysis (OR, 6.29; 95% CI, 1.05-37.49). In-hospital mortality rate was 8.9%. IEAT (OR, 3.47; 95% CI, 1.42-8.48) was an independent risk factor for mortality along with APACHE II ≥15 (OR, 3.14; 95% CI, 1.24-7.90), dementia (OR, 3.10; 95% CI, 1.19-8.07) and neoplasia (OR, 3.49; 95% CI, 1.13-10.77). IEAT was not associated with length of stay in hospital. CONCLUSION:IEAT is associated with mortality in elderly patients with UTI admitted to a non-ICU ward, suggesting that improving empirical antimicrobial therapy could have a favorable impact on prognosis. Published by Elsevier B.V.
Authors: Philipp J Spachmann; Matthias May; Malte W Vetterlein; Hans-Martin Fritsche; Steffen Steffen; Martin Schostak; Florian M Wagenlehner; Maximilian Burger; Karsten-Henrich Weylandt; Bernd Salzberger; Sabine D Brookman-May; Christian Gilfrich Journal: Caspian J Intern Med Date: 2019
Authors: E Álvarez Artero; A Campo Núñez; M Garcia Bravo; I García García; M Belhassen Garcia; J Pardo Lledías Journal: Rev Esp Quimioter Date: 2021-04-15 Impact factor: 1.553
Authors: Sang Heon Lee; Jungyo Suh; Hyung Suk Kim; Young Ju Lee; Sang Rim Lee; Khae Hawn Kim; Chang Wook Jeong Journal: Investig Clin Urol Date: 2017-01-09
Authors: Manuel Madrazo; Ana Esparcia; Ian López-Cruz; Juan Alberola; Laura Piles; Alba Viana; José María Eiros; Arturo Artero Journal: BMC Infect Dis Date: 2021-12-07 Impact factor: 3.090